Camarata Stephen
Vanderbilt University School of Medicine , TN , USA.
Int J Speech Lang Pathol. 2014 Feb;16(1):61-8. doi: 10.3109/17549507.2013.864708.
The papers on early identification and early intervention for autism spectrum disorders (ASD) in this scientific forum (published in volume 16(1) International Journal of Speech-Language Pathology) raise many important points, including describing the substantial progress made to date as well as analyses of current gaps and weaknesses in the existing evidence base. It is humbling to see the collective expertise of the distinguished authors contributing to this scientific forum including interdisciplinary perspectives and it is not surprising that there is ongoing debate on this important topic. In addition to discussing the points raised by these authors, this paper considers the implications of the new diagnostic criteria for ASD and for social communication disorder (SCD) in the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) in the US. Differential diagnosis of ASD and SCD will be paramount in testing early intervention for ASD and the expertise of speech-language pathologists in identifying SCD in infants and toddlers will be a central feature of discovery for both early identification and for early intervention in the decades to come. Finally, a biomedical example on testing early intervention on a spectrum disorder, derived from diabetes, is presented to illustrate both the promise and the pitfalls in testing interventions in the absence of well-validated assessment and intervention paradigms.
本次科学论坛中关于自闭症谱系障碍(ASD)早期识别与早期干预的论文(发表于《国际言语病理学杂志》第16卷第1期)提出了许多要点,包括阐述了迄今所取得的重大进展以及对现有证据基础中当前差距与不足的分析。看到众多杰出作者的集体专业知识为本次科学论坛做出贡献,包括跨学科视角,令人深感谦卑,而且在这个重要话题上存在持续的争论也不足为奇。除了讨论这些作者提出的要点外,本文还考虑了美国《精神疾病诊断与统计手册》第5版(DSM - 5)中ASD和社交沟通障碍(SCD)新诊断标准的影响。ASD和SCD的鉴别诊断对于测试ASD的早期干预至关重要,并且言语语言病理学家在识别婴幼儿SCD方面的专业知识将成为未来几十年早期识别和早期干预发现的核心特征。最后,给出一个源于糖尿病的针对谱系障碍测试早期干预的生物医学实例,以说明在缺乏充分验证的评估和干预范式的情况下测试干预措施的前景与陷阱。